Target
Ubiquitin carboxyl-terminal hydrolase isozyme L1
Ligand
BDBM445155
Substrate
n/a
Meas. Tech.
UCHL1 Biochemical IC50 Assay
IC50
550±n/a nM
Citation
 Kemp, MStockley, MJones, A Cyanopyrrolidines as dub inhibitors for the treatment of cancer US Patent  US10669234 Publication Date 6/2/2020 
Target
Name:
Ubiquitin carboxyl-terminal hydrolase isozyme L1
Synonyms:
Neuron cytoplasmic protein 9.5 | PGP 9.5 | PGP9.5 | UCH-L1 | UCHL1 | UCHL1_HUMAN | Ubiquitin thioesterase L1
Type:
PROTEIN
Mol. Mass.:
24819.03
Organism:
Homo sapiens (Human)
Description:
ChEMBL_974327
Residue:
223
Sequence:
MQLKPMEINPEMLNKVLSRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVYFMKQTIGNSCGTIGLIHAVANNQDKLGFEDGSVLKQFLSETEKMSPEDRAKCFEKNEAIQAAHDAVAQEGQCRVDDKVNFHFILFNNVDGHLYELDGRMPFPVNHGASSEDTLLKDAAKVCREFTEREQGEVRFSAVALCKAA
  
Inhibitor
Name:
BDBM445155
Synonyms:
(S)-N-(4-(3-Chlorophenyl)thiazol-2-yl)-1-cyano-N-ethylpyrrolidine-2-carboxamide | US10669234, Example 109 | US11319287, Example 109
Type:
Small organic molecule
Emp. Form.:
C21H26ClN3O3S
Mol. Mass.:
435.967
SMILES:
CCN(C(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C)c1nc(cs1)-c1cccc(Cl)c1 |r|
Structure:
Search PDB for entries with ligand similarity: